Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Tarka · SciRah

Researcher profile · Semantic Scholar

E. Tarka

Share profile

E. Tarka — researcher profile on SciRah

h-index: 13
Works: 22
Citations: 1,579

Most-cited papers

Darapladib for preventing ischemic events in stable coronary heart disease.
H. White, C. Held, R. Stewart, E. Tarka +56 more
2014New England Journal of Medicine546 citations Open access
Semantic Scholar
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
M. O'Donoghue, E. Braunwald, H. White, D. Steen +17 more
2014Journal of the American Medical Association (JAMA)363 citations
Semantic Scholar
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
H. White, C. Held, R. Stewart, David Watson +9 more
2010American Heart Journal123 citations
Semantic Scholar
Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
E. Hagström, C. Held, R. Stewart, P. Aylward +11 more
2017Clinical Chemistry114 citations Open access
Semantic Scholar
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.
M. O'Donoghue, E. Braunwald, H. White, P. Serruys +10 more
2011American Heart Journal90 citations
Semantic Scholar
Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging.
A. Tawakol, Parmanand Singh, J. Rudd, J. Soffer +10 more
2014Journal of the American College of Cardiology83 citations Open access
Semantic Scholar
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: An open‐label, safety, efficacy, and pharmacokinetic study
G. Young, L. Boshkov, J. E. Sullivan, L. Raffini +6 more
2011Pediatric Blood & Cancer65 citations
Semantic Scholar
Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
L. Wallentin, C. Held, P. Armstrong, C. Cannon +57 more
2016Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease47 citations Open access
Semantic Scholar
Controlled-release carvedilol in the treatment of essential hypertension.
M. Weber, D. Sica, E. Tarka, M. Iyengar +2 more
2006American Journal of Cardiology35 citations
Semantic Scholar
Importance of blood pressure control in left ventricular mass regression.
Alan Miller, N. Reichek, M. S. St. John Sutton, M. Iyengar +3 more
2010Journal of the American Society of Hypertension : JASH30 citations
Semantic Scholar
Peripheral artery disease, biomarkers, and darapladib
J. Berger, C. Ballantyne, M. Davidson, Joel L. Johnson +5 more
2011American Heart Journal24 citations Open access
Semantic Scholar
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib
A. Yeo, Li Li, L. Warren, J. Aponte +12 more
2017PLoS ONE22 citations Open access
Semantic Scholar
Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.
G. Fonarow, P. Deedwania, V. Fonseca, R. Nesto +5 more
2009Journal of the American Society of Hypertension : JASH14 citations
Semantic Scholar
Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile.
G. Bakris, E. Tarka, B. Waterhouse, Michelle R Goulding +5 more
2006American Journal of Cardiology9 citations
Semantic Scholar
Lipoprotein-Associated Phospholipase A 2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
L. Wallentin, C. Held, P. Armstrong, C. Cannon +16 more
20168 citations
Semantic Scholar
Echocardiographic and vascular ultrasound evaluation of cerebrovascular ischemic events
F. Silvestry, E. Tarka, E. Mohler
19985 citations Open access
Semantic Scholar
Effect of Darapladib onMajor Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
M. O'Donoghue, E. Braunwald, H. White, D. Steen +17 more
20142 citations
Semantic Scholar
GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) FOR PROGNOSTICATION OF OUTCOMES IN STABLE CORONARY ARTERY DISEASE: EXPERIENCES FROM THE STABILITY TRIAL
L. Wallentin, C. Held, R. Stewart, A. Budaj +9 more
20151 citations Open access
Semantic Scholar
Abstract 18682: Inflammatory Biomarkers for Prognostication of Outcomes in Stable Coronary Artery Disease - Experiences From the STABILITY Trial
C. Held, H. White, R. Stewart, A. Budaj +9 more
20141 citations
Semantic Scholar
Peripheral Vascular Disease Peripheral artery disease , biomarkers , and darapladib
Jeffrey S. Berger, C. Ballantyne, Michael H. Davidson, Joel L. Johnson +5 more
20110 citations
Semantic Scholar
Darapladib and atherosclerosis
H. Garcia-Garcia, E. Tarka, C. Macphee, P. Serruys
2010Drugs of the future0 citations
Semantic Scholar
METHODE DE TRAITEMENT A L'ARGATROBAN POUR DES PATIENTS SOUFFRANT DE THROMBOCYTOPENIE INDUITE PAR L'HEPARINE
M. M. Gardner, M. J. Hursting, E. Tarka, C. Verme-Gibboney
20050 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. White×11
Invite
H. White — researcher profile on SciRah
C. Cannon×10
Invite
C. Cannon — researcher profile on SciRah
L. Wallentin×8
Invite
L. Wallentin — researcher profile on SciRah
C. Held×7
Invite
C. Held — researcher profile on SciRah

×7

Invite

R. Stewart — researcher profile on SciRah

Invite

P. Steg — researcher profile on SciRah

Invite

R. Davies — researcher profile on SciRah

Invite

J. Hochman — researcher profile on SciRah

Invite

W. Koenig — researcher profile on SciRah

Invite

E. Mohler — researcher profile on SciRah

S. Krug‐Gourley×6

Invite

S. Krug‐Gourley — researcher profile on SciRah

Invite

A. Budaj — researcher profile on SciRah